Abstract:BackgroundCardiac Implantable Electronic Devices (CIEDs) are widely used for the management of advanced heart failure and ventricular arrhythmias. CIED‐Infection (CIED‐I) has very high mortality, especially in the subsets of patients with limited health‐care access and delayed presentation. The purpose of this study is to identify the risk‐predictors mortality in subjects with CIED‐I.MethodsWe performed a retrospective cohort study of a regional database in patients presenting with CIED infections to tertiary care medical centers across Western New York, USA from 2012 – 2020. The clinical outcomes included recurrent device infection (any admission for CIED‐I after the first hospitalization for device infection), septic complications (pulmonary embolism, respiratory failure, septic shock, decompensated HF, acute kidney injury) and mortality outcomes (death during hospitalization, within 30 days from CIED‐I, and within 1 year from CIED‐I). We studied associations between categorical variables and hard outcomes using chi‐square tests and used one‐way analysis of variance to measure between‐groups differences.ResultsWe identified 296 patients with CIED‐I, among which 218 (74%) were male, 237 (80%) were white and the mean age at the time of infection was 69.2±13.7 years. One‐third of the patients were referred from the regional facilities. Staphylococcus aureus was responsible for most infections, followed by Enterococcus fecalis. On multivariate analysis, the covariates associated with significantly increased mortality risk included referral from regional facility (OR: 2.0;1.0‐4.0), hypertension (Odds ratio, OR: 3.2;1.3‐8.8), right ventricular dysfunction (OR: 2.6;1.2‐5.1), end‐stage renal disease (OR: 2.6;1.1‐6.2), immunosuppression (OR: 11.4;2.5‐53.3), and septic shock as a complication of CIED‐I (OR: 3.9;1.3‐10.8).ConclusionHypertension, right ventricular dysfunction, immunosuppression, and end‐stage renal disease are associated with higher mortality after CIED‐I. Disproportionately higher mortality was also noted in subjects referred from the regional facilities. This underscores the importance of early clinical risk‐assessment, and the need for a robust referral infrastructure to improve patient outcomes.This article is protected by copyright. All rights reserved.

Tailored Care for Cardiac Health: Risk Stratification and Gentamicin-Infused Collagen Sponges to Minimize Cardiac Device Infections and Healthcare Costs

Prevention and Risk Assessment of Cardiac Device Infections in Clinical Practice

Burden of disease and costs of infections associated with cardiac implantable electronic devices

Antibiotic Prophylaxis and Treatment for Cardiac Device Infections

New advances in management and treatment of cardiac implantable electronic devices infections

Measures to Prevent Infection in Cardiac Implantable Electronic Device Replacements or Upgrades

Prevention and Management of Cardiac Implantable Electronic Device Infections: State-of-the-Art and Future Directions

Mortality and Costs of Cardiac Implantable Electronic Device (CIED) Infections According to the Therapeutic Approach: A Single-Center Cohort Study

Device infection in patients undergoing pacemaker or defibrillator surgery: risk stratification using the PADIT score

Infective Endocarditis Involving Implanted Cardiac Electronic Devices: JACC Focus Seminar 1/4

Antibiotic-Eluting Envelopes to Prevent Cardiac-Implantable Electronic Device Infection: Past, Present, and Future

Risk Factors Associated with Higher Mortality in Patients with Cardiac Implantable Electronic Device Infection

Evidence-Based Strategies to Promote Long-Term Cardiac Implant Site Health: Review of the Literature

Trends in Managing Cardiac and Orthopaedic Device-Associated Infections by Using Therapeutic Biomaterials

Cardiovascular Implantable Electronic Device Infections: A Contemporary Review

Risk of Cardiovascular Implantable Electronic Device Infection in Patients Presenting With Gram-Negative Bacteremia

Cardiac implantable electronic devices and bloodstream infections: management and outcomes

Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry

Risk of infections related to endovascular catheters and cardiac implantable devices in hemodialysis patients

Cardiac device infections: getting to the heart of the matter

Abstract 15148: Contemporary Trends of Antibacterial Envelope Use to Prevent Cardiac Implantable Device Infection: Insights From the National Readmission Database